Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
Pharmacy - Special Processed Drugs - FDA Approved Cell Therapy (RC 0891) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved October 14, 2026 , from http://ppman.hank.ai/transparency/procedure/0891/by-state?code_type=RC
“Pharmacy - Special Processed Drugs - FDA Approved Cell Therapy (RC 0891) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/0891/by-state?code_type=RC. Accessed
October 14, 2026 .
“Pharmacy - Special Processed Drugs - FDA Approved Cell Therapy (RC 0891) by State,” HANK Price Transparency ,
accessed October 14, 2026 ,
http://ppman.hank.ai/transparency/procedure/0891/by-state?code_type=RC.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
RC · across United States
0891 — Pharmacy - Special Processed Drugs - Fda Approved Cell Therapy
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$8,427
National median
$30 – $22,981
IQR (p25 – p75)
37
hospitals filing
9
states
Walking in without insurance?
Cash / self-pay price
Cash median
$22
vs. negotiated
-99.7%
Hospitals reporting
9
Cash / self-pay rates apply when you don't run the bill through insurance.
Many hospitals also offer income-based discounts on top of the published
cash price — always ask about a financial-assistance application
before paying.
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 0891 (RC), with interquartile range
State Median p25 p75
PA $462,000 $85 $531,350
ND $27,566 $27,566 $27,566
TX $9,530 $8,427 $22,653
IL $8,997 $8,997 $8,997
CO $77 $74 $80
MN $74 $74 $74
NY $74 $28 $15,370
KY $48 $30 $50
MI $28 $15 $28